Fund BasicsSee More
- Fund Family N/A
- Assets Under Management 0
- Shares Outstanding, K 9,088
- 60-Month Beta -8.61
- Price/Earnings ttm N/A
- Annual Dividend & Yield N/A
- Most Recent Dividend N/A
- Management Fee N/A
|Period||Period Low||Period High||Performance|
| || |
-25.33 (-18.40%)since 06/02/20
| || |
-216.66 (-65.85%)since 04/02/20
| || |
-44.14 (-28.20%)since 07/02/19
The first-half of 2020 was marked with the outbreak of SARS (severe acute respiratory syndrome)-like coronavirus.
The stock market volatility returned with growing fears of a second wave of coronavirus infections and a gloomy economic outlook provided by the Fed.
Investors rushed to leveraged or inverse leveraged ETFs to increase returns on quick market turns in a short span.
The spike in number of COVID-19 cases has renewed fears that the outbreak would turn into a pandemic resulting in market volatility.
Wall Street's rally fizzled out to start December with fresh trade tensions and downbeat U.S. data, pushing volatility products higher.
Credit Suisse AG announced today that it will implement a 1-for-5 reverse split of its VelocityShares(TM) VIX Short Term ETN ("VIIX") and a 1-for-10 reverse split of its VelocityShares(TM) Daily 2x VIX...
We take a look at the 10 biggest and most-popular ETFs for those investors who are new to the leveraged technique.
Inside the top-and-worst-performing leveraged ETFs of last week amid renewed hopes of U.S.-China trade talks.
We have highlighted short-term volatility products that will steadily move higher as long as trade concerns linger.
The Zacks Analyst Blog Highlights: VXX, VIXY, VIIX, UVXY and TVIX
|3rd Resistance Point||N/A|
|2nd Resistance Point||120.75|
|1st Resistance Point||116.56|
|1st Support Level||106.03|
|2nd Support Level||99.69|
|3rd Support Level||N/A|